{"id":40948,"date":"2020-01-30T13:59:47","date_gmt":"2020-01-30T21:59:47","guid":{"rendered":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2020\/01\/30\/australia-expedites-review-of-medical-cannabis-product-epidiolex\/"},"modified":"2020-01-31T00:36:35","modified_gmt":"2020-01-31T08:36:35","slug":"australia-expedites-review-of-medical-cannabis-product-epidiolex","status":"publish","type":"post","link":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2020\/01\/30\/australia-expedites-review-of-medical-cannabis-product-epidiolex\/","title":{"rendered":"Australia expedites review of medical cannabis product Epidiolex"},"content":{"rendered":"<\/p>\n<p>The only medical cannabis product in the Australian Register of Therapeutic Goods might soon be joined by another. Australian health regulators quietly gave Epidiolex, a cannabidiol medication, orphan designation and priority review status in late 2019. The designations allow the Therapeutic Goods Administration to wave application and evaluation fees, as well as expediting its assessment [\u2026]<\/p>\n<p><a rel=\"nofollow\" href=\"https:\/\/mjbizdaily.com\/australia-expedites-review-of-medical-cannabis-product-epidiolex\/\">Australia expedites review of medical cannabis product Epidiolex<\/a> is a post from: <a href=\"http:\/\/mjbizdaily.com\">Marijuana Business Daily: Financial, Legal &amp; Cannabusiness news for cannabis entrepreneurs<\/a><\/p>\n<p>&#013;<br \/>\n&#013;<br \/>\nRead More: <a href=\"https:\/\/mjbizdaily.com\/australia-expedites-review-of-medical-cannabis-product-epidiolex\/\" target=\"_blank\">Australia expedites review of medical cannabis product Epidiolex<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The only medical cannabis product in the Australian Register of Therapeutic Goods might soon be joined by another. Australian health regulators quietly gave Epidiolex, a cannabidiol medication, orphan designation and priority review status in late 2019. The designations allow the Therapeutic Goods Administration to wave application and evaluation fees, as<span class=\"more-link\"><a href=\"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2020\/01\/30\/australia-expedites-review-of-medical-cannabis-product-epidiolex\/\">Continue Reading<\/a><\/span><\/p>\n","protected":false},"author":79,"featured_media":0,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[10247,271,713,9662,3156,1393,2043,2786,4613],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/40948"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/79"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=40948"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/40948\/revisions"}],"predecessor-version":[{"id":40949,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/40948\/revisions\/40949"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=40948"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=40948"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=40948"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}